North Crest Asset Manangement, LLC Lexa Gene Holdings Inc. Transaction History

North Crest Asset Manangement, LLC

$2.85 Billion
Q1 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 01, 2023	BUY	$0.1 - $0.21 $4,300 - $9,030	43,000 Added 49.43%	130,000 $14,000
Q3 2022 Oct 17, 2022	BUY	$0.08 - $0.15 $2,880 - $5,400	36,000 Added 70.59%	87,000 $9,000
Q2 2022 Jul 18, 2022	BUY	$0.11 - $0.18 $3,135 - $5,130	28,500 Added 126.67%	51,000 $6,000
Q1 2022 Apr 18, 2022	BUY	$0.16 - $0.32 $3,600 - $7,200	22,500 New	22,500 $4,000

Others Institutions Holding LXXGF

# of Institutions

2

Shares Held

381K

Call Options Held

0

Put Options Held

0

Atlas Capital Advisors LLC San Francisco, CA

320K
Shares

$25,600
0.0% of portfolio
Connectus Wealth, LLC Cincinnati, OH

61.1K
Shares

$4,884
0.0% of portfolio

About LexaGene Holdings Inc.

Ticker LXXGF
Exchange OTC
Description
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life science...

More about LXXGF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.